European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2023 update
M Rouprêt, T Seisen, AJ Birtle, O Capoun… - European urology, 2023 - Elsevier
Abstract Context The European Association of Urology (EAU) guidelines panel on upper
urinary tract urothelial carcinoma (UTUC) has updated the guidelines to aid clinicians in …
urinary tract urothelial carcinoma (UTUC) has updated the guidelines to aid clinicians in …
The 2022 World Health Organization classification of tumors of the urinary system and male genital organs—part B: prostate and urinary tract tumors
Abstract The 2022 World Health Organization (WHO) classification of the urinary and male
genital tumors was recently published by the International Agency for Research on Cancer …
genital tumors was recently published by the International Agency for Research on Cancer …
[HTML][HTML] Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
T Powles, J Bellmunt, E Comperat… - Annals of …, 2022 - annalsofoncology.org
Urothelial carcinoma (UC), also described as bladder cancer, is the 10th most common
cancer type worldwide, with an estimated 549 000 new cases and 200 000 deaths in 2018 …
cancer type worldwide, with an estimated 549 000 new cases and 200 000 deaths in 2018 …
European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update
M Rouprêt, M Babjuk, M Burger, O Capoun, D Cohen… - European urology, 2021 - Elsevier
Abstract Context The European Association of Urology (EAU) Guidelines Panel on Upper
Urinary Tract Urothelial Carcinoma (UTUC) has prepared updated guidelines to aid …
Urinary Tract Urothelial Carcinoma (UTUC) has prepared updated guidelines to aid …
Neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma: a 2020 systematic review and meta-analysis, and future perspectives on systemic …
JJ Leow, YL Chong, SL Chang, BP Valderrama… - European urology, 2021 - Elsevier
Context To improve the prognosis of upper tract urothelial carcinoma (UTUC), clinicians
have used neoadjuvant chemotherapy (NAC) or adjuvant chemotherapy (AC) before or after …
have used neoadjuvant chemotherapy (NAC) or adjuvant chemotherapy (AC) before or after …
[HTML][HTML] Systematic overview of aristolochic acids: nephrotoxicity, carcinogenicity, and underlying mechanisms
J Han, Z Xian, Y Zhang, J Liu, A Liang - Frontiers in Pharmacology, 2019 - frontiersin.org
Aristolochic acids (AAs) are a group of toxins commonly present in the plants of genus
Aristolochia and Asarum, which are spread all over the world. Since the 1990s, AA-induced …
Aristolochia and Asarum, which are spread all over the world. Since the 1990s, AA-induced …
[HTML][HTML] Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
Current non-invasive approaches for detection of urothelial cancers are suboptimal. We
developed a test to detect urothelial neoplasms using DNA recovered from cells shed into …
developed a test to detect urothelial neoplasms using DNA recovered from cells shed into …
Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis
F Janisch, SF Shariat, P Baltzer, H Fajkovic… - World journal of …, 2020 - Springer
Purpose To systematically review the literature evaluating the performance of MDCTU for
the diagnosis of UTUC and meta-analyse available data. We also compared the diagnostic …
the diagnosis of UTUC and meta-analyse available data. We also compared the diagnostic …
Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: an European Association of …
B Peyronnet, T Seisen, JL Dominguez-Escrig… - European urology …, 2019 - Elsevier
Context Most series have suggested better perioperative outcomes of laparoscopic radical
nephroureterectomy (RNU) over open RNU. However, the oncological safety of …
nephroureterectomy (RNU) over open RNU. However, the oncological safety of …
Novel use of circulating tumor DNA to identify muscle-invasive and non–organ-confined upper tract urothelial carcinoma
HL Huelster, B Gould, EA Schiftan, L Camperlengo… - European urology, 2024 - Elsevier
Background Optimal patient selection for neoadjuvant chemotherapy prior to surgical
extirpation is limited by the inaccuracy of contemporary clinical staging methods in high-risk …
extirpation is limited by the inaccuracy of contemporary clinical staging methods in high-risk …